Drug Topics
JULY 10, 2023
As costs increase and the number of people in need further outpaces resources, it becomes increasingly urgent to find ways to further extend services to the people who need them.
PhRMA
JULY 10, 2023
A new report showcasing nine critical oncology treatments, highlights the vital role of post-approval research and development (R&D) in advancing cancer treatment options and delivering unprecedented progress in the fight against cancer over the past 10 years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 10, 2023
Our groundbreaking analysis of customer data uncovered valuable insights to empower pharmacies. Our annual reports shed light on enhanced data transparency and savings opportunities, helping pharmacies make informed decisions and drive efficiency.
PharmaVoice
JULY 10, 2023
A report from IQVIA shows China gaining ground in cancer drug R&D, and a growing industry focus on new drug targets.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JULY 10, 2023
Join RPhAlly for three nights of education with industry leaders from July 18-20.
Pharmacy Times
JULY 10, 2023
Aside from the clinically significant risks associated with polypharmacy, an increased pill burden can be unaffordable and difficult to manage.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JULY 10, 2023
When a patient is engaged in the home by a team that includes a pharmacist resource, social determinants of health issues become more clear and the care team can help close the gaps.
Drug Topics
JULY 10, 2023
The company will also add Sandoz’s unbranded version of adalimumab to its National Preferred Formulary.
Pharmacy Times
JULY 10, 2023
Pre-exposure prophylaxis of neutralizing SARS-CoV-2 monoclonal antibodies may be preventative against SARS-CoV-2 transmission, decreasing frequency of new infections and number of hospitalized patients who need antiviral therapies, thus lowering costs.
PharmExec
JULY 10, 2023
Join five industry leaders as they unpack the transformative potential of artificial intelligence in the pharmaceutical industry, offering insights into real-world applications and the future of life sciences marketing in an era shaped by rapid technological evolution.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 10, 2023
Clostridioides difficile infection can be difficult to treat, but increasing disease awareness can improve screening and treatment outcomes.
Fierce Pharma
JULY 10, 2023
Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbust | Two cases of suicidal thoughts and one case of self-harm from users in Iceland of Novo Nordisk’s diabetes and obesity drugs have prompted the European Medicines Agency (EMA) to review the blockbuster products.
pharmaphorum
JULY 10, 2023
J&J snaps up Nanobiotix cancer radiotherapy in $2.5bn+ deal Phil.
Fierce Healthcare
JULY 10, 2023
Telehealth came into its own during the COVID-19 pandemic< | Researchers found that for most specialties patients were more likely to have an in-person follow-up visit 90 days after an in-person visit rather than a telehealth visit.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 10, 2023
Patient data should be owned and controlled by individuals Mike.
STAT
JULY 10, 2023
One month it was pizza. Starting in the late afternoon, while he was teaching a chem lab or grading student work, a part of Anthony Fernandez’s brain would stray to visions of steaming pies. The thought of sinking his teeth into one would tug at him as he packed up his things and walked to his car. By the time he pulled out of the Merrimack College campus, the urge would become a tractor beam, reeling him into the small shop just shy of Route 125 for a slice or three.
The Checkup by Singlecare
JULY 10, 2023
Prednisone is a commonly used oral steroid prescription medication prescribed to treat inflammatory conditions like arthritis and autoimmune disorders. The corticosteroid medication decreases your immune system’s response to various conditions and reduces swelling and allergic reaction symptoms. Doctors prescribe prednisone to treat multiple conditions, from blood disorders to breathing problems, cancer, eye infections, and severe poison ivy.
STAT
JULY 10, 2023
For Jack Johnson, getting diagnosed with Fabry disease at age 7 was more of a formality. He’d been experiencing symptoms for several years already, and had watched multiple family members struggle with the rare condition. But around 7 was when Johnson’s pain started — triggered by exercise or being outdoors when it was too hot. Fabry disease is characterized by a buildup of the fatty lipid Gb3, which can cause gastrointestinal issues, kidney failure, stroke, chronic pain, an
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
JULY 10, 2023
As of 7 July 2023, the European Medicines Agency (EMA) has updated its guidance on nitrosamine impurities. The regulatory body has amended Q&A 10 to include the Carcinogenic Potency Categorization Approach (CPCA) and the enhanced Ames test (EAT) for establishing acceptable intakes (AIs) for N -nitrosamines. The assessment report of the Committee for Medicinal Products for Human Use (CHMP)’s Article 5(3) of Regulation (EC) No 726/2004 opinion on nitrosamine impurities in human medicinal produ
STAT
JULY 10, 2023
It took Richard Huckabee nine years to get a Parkinson’s diagnosis. A district manager for a convenience store chain, he first noticed symptoms in 2004 when his voice would suddenly falter while speaking to large groups of employees. “It’s probably just stress,” Huckabee remembered his doctor saying. A year later came the brain fuzziness, with Huckabee forgetting his colleagues’ names, having his thoughts freeze mid-conversation, and fully losing his ability to
PharmExec
JULY 10, 2023
Artificial intelligence is steadily becoming a game changer for the pharma industry, particularly in commercialization activities, such as sales and marketing—and efforts to help highly sought treatments reach the right patients.
STAT
JULY 10, 2023
Despite remarkable progress in health and medicine, biology’s final frontiers remain beyond our reach. Humanity has not yet cured Alzheimer’s or ended cancer, and was unable to prevent Covid-19 from growing into a pandemic. As physicians and scientists, we understand the frustration of patients who still feel left behind despite the marvels of modern medicine.
Drug Store News
JULY 10, 2023
Xiidra is a prescription eye drop used to treat dry eye disease.
pharmaphorum
JULY 10, 2023
Disease X is coming. Are we ready? Mike.
STAT
JULY 10, 2023
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating because that oh-so-predictable routine of meetings and online calls has returned. But what can you do? The world, such as it is, continue to spin no matter how hard we try to slow it down. So time to give it a nudge in a better direction.
pharmaphorum
JULY 10, 2023
AI-based heart disease tool wins Future NHS Award Phil.
PharmExec
JULY 10, 2023
COMPASS Pathways’ CEO, Kabir Nath, has a clear vision for psychedelics—and is leading the way with the company’s focus on psilocybin and efforts to separate the science from the hype.
European Pharmaceutical Review
JULY 10, 2023
In a world-first clinical trial published Nature Medicine , a multi-centre study found 65 percent of advanced melanoma patients who retained the donors’ microbiome after a faecal microbiota transplants (FMT) had a clinical response to immunotherapy. While immunotherapy drugs can significantly improve survival outcomes in melanoma, they are only effective in 40 to 50 percent of patients.
pharmaphorum
JULY 10, 2023
Uptake of Leqembi for Alzheimer’s may be slow Phil.
European Pharmaceutical Review
JULY 10, 2023
Traditional methods for assessing microbial contamination in pharmaceutical products can take weeks: sterility testing for final product requires 14 days of incubation (per USP <71> and Ph. Eur. 2.6.1), while mycoplasma determination in cell cultures can take up to 28 days (USP <63>, Ph. Eur. 2.6.7). Given their short shelf-life, there is a need for methods that generate more rapid results for emerging advanced therapy medicinal products (ATMPs) such as cell and gene therapies.
Drug Store News
JULY 10, 2023
The new store preserves and celebrates the history of the iconic Nutty Brown site, the retailer said.
STAT
JULY 10, 2023
A program that undergirds the Affordable Care Act’s health insurance marketplaces continues to bolster the balance sheets of large Blue Cross Blue Shield companies, according to a STAT analysis of new federal data. Conversely, that same program — called “risk adjustment” — has created substantial financial burdens for startup insurers including Bright Health Group, which has now exited all health insurance markets, and Friday Health Plans, which has shut down.
Drug Store News
JULY 10, 2023
Sally Hansen’s Xtreme Wear Concrete Jungle collection features 10 trendy shades formulated with vegan ingredients, the company said.
Expert insights. Personalized for you.
359 
Let's personalize your content